Companies in the oncology sector developing innovative solutions and technologies.
Explore 295 recently funded oncology companies with verified founder contact information and fundraising data.
Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.
KuriBio builds a nanotechnology platform for therapeutic applications in oncology and beyond.
Haemalogix focuses on the development and commercialization of novel immuno-oncology and immune-therapies.
Solid Therapeutics develops novel cancer therapeutics with dual performance targeting cancer cells and immune cells to treat solid tumors.
Pleco Therapeutics is a pharmaceutical manufacturing company that provides pre-clinical development programs for cancer treatment.
Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.
Epigene Labs designs genomics-driven drug for precision oncology.
Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.
Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.
CompagOs is developing a blood-based test to help oncologists detect bone metastases early with mineralized bone models.
Precision Epigenomics is a molecular diagnostic company that develops molecular diagnostic assays for cancer diagnosis.
Gradient Medical develops novel interventional oncology services to bring ACE therapy to the clinic.
Bantam Pharmaceutical has deep experience in oncology drug discovery and development including R&D and partnering.
Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.
Enzee develops applications for the radiology, radiation oncology, and radiation safety communities.
Wanda Health provides applications and machine learning based health informatics for remote health and patient management.
Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
Advanced Microbubbles platform enables safe and precise drug delivery for cancer treatment.
Filtricine provides new solution to cancer care via Targeted Nutrients Deprivation.
Specializes in the development of nanoparticles for cancer treatment.
CancerIQ provides a precision prevention platform that empowers community-based providers to prevent cancer.
Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.
Saccharo is a biotech start-up in the immuno-oncology space that develops products for the treatment of cancer and other novel diseases.
LumenAstra develops a non-invasive, wearable deep-tissue temperature sensor for cancer treatment and other applications.
The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 295 oncology companies tracked in the VCBacked database.
Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked